Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Post-marketing, Single-arm, Open Label, Multi-center Clinical Study to Evaluate the Safety and Efficacy of the ReDy™ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension

NCT02690909 is registered in ClinicalTrials.gov with Renal Dynamics GmbH as lead sponsor.

NCT NCT02690909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02690909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Post-marketing, Single-arm, Open Label, Multi-center Clinical Study to Evaluate the Safety and Efficacy of the ReDy™ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension
Lead sponsor
Renal Dynamics GmbH
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2016
Completion date
August 31, 2017
Enrollment
55 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension resistant to conventional therapy